This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Taylor, S. H. Search for Related Content PubMed PubMed Citation Articles by Taylor, S. H. Social Bookmarking                         What's this?

A Comparison of the Efficacy and Safety of Quinapril with that of Enalapril in the Treatment of Mild to Moderate Essential Hypertension

Department of Medical Cardiology General Infirmary Leeds LS1 3EX, England

This twenty-eight-week double- blind study in patients with mild to moderate essential hypertension showed quinapril (10, 20, and 40 mg/ day) to be similarly effective to enal april at the same doses in producing clinically significant reductions in sit ting DBP. Hydrochlorothiazide could be safely added to quinapril therapy in nonresponders. Quinapril and enalapril were well tolerated. Both agents can safely be administered as first-line therapy.

Angiology, Vol. 40, No. 4 part_2, 382-388 (1989)
DOI: 10.1177/000331978904000407


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. C. Olson, A. M. Horvath, B. M. Michniewicz, A. J. Sedman, W. A. Colburn, P. G. Welling, and S. C. Olson The Clinical Pharmacokinetics of Quinapril Angiology, January 1, 1989; 40(4_part_2): 351 - 359. [Abstract] [PDF]